Prostate cancer screening--the evidence, the recommendations, and the clinical implications.
about
Validation of proposed prostate cancer biomarkers with gene expression data: a long road to travelUrinary biomarkers for prostate cancerDoes robotic prostatectomy meet its promise in the management of prostate cancer?Expected population impacts of discontinued prostate-specific antigen screening.The biology of castration-resistant prostate cancerA simple schema for informed decision making about prostate cancer screening.Primary care providers' perspectives on discontinuing prostate cancer screening.Prevalence of incidental prostate cancer: A systematic review of autopsy studies.Risk perception and psychological morbidity in men at elevated risk for prostate cancerNational evidence on the use of shared decision making in prostate-specific antigen screening.Five-year downstream outcomes following prostate-specific antigen screening in older menEconomic Analysis of Prostate-Specific Antigen Screening and Selective Treatment StrategiesRobotic and standard open radical prostatectomy: oncological and quality-of-life outcomes.Screening for Prostate Cancer-Beyond Total PSA, Utilization of Novel Biomarkers.Similar perspectives on prostate cancer screening value and new guidelines across patient demographic and PSA level subgroups: A qualitative study.Tracking the clonal origin of lethal prostate cancer.Does quality of life of prostate cancer patients differ by stage and treatment?
P2860
Q27001399-14CE7BCE-580A-422B-A1A2-97EFDA43BC6AQ27009110-B71E79A0-AE47-4D6D-B3BF-51D269E280BCQ34337735-03452901-A494-450E-8236-B84C491C1D14Q34458237-A901262B-BB72-4590-8F8F-52A8DE112338Q35039889-98EECBEE-3956-4CAF-9D84-5385F6A413CFQ35546777-C91F1798-1ADB-444F-8208-E3978EB91E54Q36188117-C2C8D397-B98B-4E80-A8CE-769B9EFE5B95Q36380194-7F4A5531-B245-4A21-99FF-314029747D42Q36394622-A71DF2BF-2B3D-43D5-89E1-6DC087EA409DQ36992262-2D8F8120-3B50-48BA-973A-D43072885592Q37017183-114DD2FD-2E95-49B5-B2E7-F6AF051C1651Q37095655-F23E199B-87ED-4D32-86C6-2CE3DB84E7B7Q38162888-4FE837B3-A559-45DE-ABD3-5D5285D7E380Q38546301-F2FB8553-433B-4FB3-A817-CB52BF05286DQ41032260-31B0AC0E-5952-485E-98BC-49CFB8EA1158Q41762568-D779314C-3C32-4592-B856-D2817F9FB3AAQ48340427-DECF8E99-80CD-4764-8C11-D5254B461947
P2860
Prostate cancer screening--the evidence, the recommendations, and the clinical implications.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Prostate cancer screening--the ...... and the clinical implications.
@en
Prostate cancer screening--the ...... and the clinical implications.
@nl
type
label
Prostate cancer screening--the ...... and the clinical implications.
@en
Prostate cancer screening--the ...... and the clinical implications.
@nl
prefLabel
Prostate cancer screening--the ...... and the clinical implications.
@en
Prostate cancer screening--the ...... and the clinical implications.
@nl
P356
P1476
Prostate cancer screening--the ...... and the clinical implications.
@en
P2093
Michael L LeFevre
Roger Chou
P304
P356
10.1001/JAMA.2011.1891
P407
P577
2011-12-01T00:00:00Z